GemPharmatech Co., Ltd. (SHA:688046)

China · Delayed Price · Currency is CNY

27.78

-1.29 (-4.45%)

Oct 22, 2026, 4:00 PM EDT

Market Cap	11.37B +66.3%
Revenue (ttm)	878.13M +21.7%
Net Income	182.55M +74.9%
EPS	0.45 +79.3%
Shares Out	409.16M
PE Ratio	61.51
Forward PE	56.69
Dividend	0.22 (0.79%)
Ex-Dividend Date	Oct 22, 2026

Volume	6,130,110
Open	29.51
Previous Close	29.07
Day's Range	27.40 - 29.88
52-Week Range	12.89 - 43.47
Beta	0.87
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breed... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2017

Employees 1,692

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688046

Full Company Profile

Financial Performance

In 2025, GemPharmatech's revenue was 793.39 million, an increase of 15.51% compared to the previous year's 686.84 million. Earnings were 142.64 million, an increase of 29.88%.

Financial Statements